Funder
University of Helsinki including Helsinki University Central Hospital
Publisher
Springer Science and Business Media LLC
Reference62 articles.
1. Tsumoto K, Isozaki Y, Yagami H, Tomita M. Future perspectives of therapeutic monoclonal antibodies. Immunotherapy. 2019;11(2):119–27.
2. Shepard HM, Lewis Phillips G, Thanos CD, Feldmann M. Developments in therapy with monoclonal antibodies and related proteins. Clin Med (Lond). 2017;17:220–32.
3. Castelli MS, McGonigle P, Hornby PJ. The pharmacology and therapeutic applications of monoclonal antibodies. Pharmacol Res Perspect. 2019;7(6):e00535.
4. Urquhart L. Top product forecasts 2020 antibody therapies. Available at: https://media.nature.com/original/magazine-assets/d41573-020-00011-5/d41573-020-00011-5.pdf. Accessed 25 Mar 2021.
5. Saleem T, Qurashi H, Jamali M, Chan Gomez J, Kanderi T. Biosimilars as a future, promising solution for financial toxicity: a review with emphasis on bevacizumab. Cureus. 2020;12(7): e9300. https://doi.org/10.7759/cureus.9300.
Cited by
52 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献